Showing results (281-290 of 384) with videos related to
Sort By:
Pageof 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2022
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and LeiomyosarcomaMichael J Wagner, Yuzheng Zhang, Lee D Cranmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2020
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of RipretinibFilip Janku, Albiruni R Abdul Razak, Ping Chi, et al.Cancer Immunology Research|June 8, 2019
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical TrialShihong Zhang, Karan Kohli, R Graeme Black, et al.Gynecologic Oncology|June 28, 2017
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trialMartee L Hensley, Shreyaskumar R Patel, Margaret von Mehren, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysisKay Savage, Maryou B K Lambros, David Robertson, et al.Eclinicalmedicine|October 28, 2025
Health-related quality of life in patients with advanced soft tissue sarcoma receiving first-line palliative chemotherapy (HOLISTIC): longitudinal results from a prospective, observational cohort studyEvelyne Roets, Eugenie Younger, Robin L Jones, et al.The Lancet. Oncology|June 9, 2020
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trialJean-Yves Blay, César Serrano, Michael C Heinrich, et al.Cancers|February 15, 2022
Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type FibromatosisAnne-Rose W Schut, Emma Lidington, Milea J M Timbergen, et al.Cancers|June 24, 2022
Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor OutcomesAnne-Rose W Schut, Emma Lidington, Milea J M Timbergen, et al.Journal of Proteomics|April 25, 2021
Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometryMartina Milighetti, Lukas Krasny, Alex T J Lee, et al.Pageof 39